XML 20 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - CAD ($)
$ in Thousands
 10 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Operating activities      
Net loss from continuing operations for the period $ (56,526) $ (206,317) $ (142,698)
Items not involving cash:      
Income tax recovery     (3,609)
Change in fair value of biological assets 1,280 (5,432) (30,340)
Share-based compensation 7,410 8,566 38,698
Depreciation and amortization 920 11,582 6,296
(Gain) loss on disposition of PP&E 17 (488) (8)
Inventory obsolescence   45,913  
Transaction costs     1,279
Finance costs 917 9,261 11,070
Loss on cancellation of contracts   671  
Loss on financial obligation 18,485   60,308
Unrealized foreign exchange loss (gain)   (757) 671
Restructuring costs   448  
Warrants issued for services   306  
Asset impairment 523 79,191 162
Change in non-cash working capital 1,217 (5,259) (41,626)
Net cash used in operating activities from continuing operations (25,757) (62,315) (99,797)
Net cash provided by operating activities from discontinued operations   4,820 (12,939)
Net cash used in operating activities (25,757) (57,495) (112,736)
Investing activities      
Additions to property, plant and equipment (76,321) (3,024) (110,271)
Additions to intangible assets   (150)  
Proceeds from disposal of PP&E   2,109 51
Additions to long-term investments   (51,876)  
Acquisition of Bridge Farm     (77,023)
Change in non-cash working capital 10,282 (11,319) 1,659
Net cash used in investing activities from continuing operations (66,039) (64,260) (185,584)
Net cash used in investing activities from discontinued operations   (6,617) (27,560)
Net cash used in investing activities (66,039) (70,877) (213,144)
Financing activities      
Proceeds from convertible notes, net of costs 27,764 18,070 90,373
Change in restricted cash   10,494 (15,477)
(Repayment) proceeds from Syndicated Credit Agreement, net of costs   (84,493) 82,687
Payments on lease obligations (34) (420) (292)
Proceeds from issuance of shares, net of costs 36,616 181,841 177,202
Proceeds from Term Debt Facility, net of costs     105,539
(Repayment) proceeds from other debt instruments 40,705   (89,044)
Proceeds from exercise of derivative warrant liabilities   20,391  
Proceeds from exercise of equity classified warrants 2,182   17,950
Proceeds from exercise of employee warrants 2,033   1,371
Settlement of convertible notes     (4,190)
Settlement of financial obligation     (9,500)
Repurchase of shares (9,634)    
Change in non-cash working capital (1,393) (2,498) 2,147
Net cash provided by financing activities from continuing operations 98,239 143,385 358,766
Net cash used in financing activities from discontinued operations   (639) (499)
Net cash provided by financing activities 98,239 142,746 358,267
Effect of exchange rate changes on cash held in foreign currency   665 (1,472)
Impact of foreign currency translation from discontinued operations     301
Change in cash and cash equivalents 6,443 15,039 31,216
Cash and cash equivalents, beginning of period 7,678 45,337 14,121
Cash and cash equivalents, end of period $ 14,121 $ 60,376 $ 45,337